Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome
NACompletedINTERVENTIONAL
Enrollment
221
Participants
Timeline
Start Date
January 18, 2013
Primary Completion Date
July 18, 2016
Study Completion Date
August 9, 2023
Conditions
Venous Thromboembolism
Interventions
BIOLOGICAL
Extra Blood Draw
Trial Locations (1)
13005
Assistance Publique Hôpitaux de Marseille, Marseille
All Listed Sponsors
lead
Assistance Publique Hopitaux De Marseille
OTHER
NCT02904967 - Identification of New Genetic Markers of Risk of Venous Thromboembolism Recurrence by Analyzing Whole Genome | Biotech Hunter | Biotech Hunter